Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy

被引:1
|
作者
Sieja, K [1 ]
Talerczyk, M [1 ]
机构
[1] Pomerania Acad Med, Dept Pharmacol, PL-70111 Szczecin, Poland
关键词
D O I
10.1016/j.ygyno.2004.11.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:559 / 560
页数:2
相关论文
共 50 条
  • [1] Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
    Sieja, K
    Talerczyk, M
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 320 - 327
  • [2] Does physical activity improve chemotherapy completion in women receiving chemotherapy for ovarian cancer?
    Beesley, Vanessa L.
    Ross, Tanya L.
    Na, Nina
    Sivakumaran, Tharani
    Au-Yeung, George
    Nagle, Christina M.
    deFazio, Anna
    Grant, Peter
    Obermair, Andreas
    Friedlander, Michael
    Webb, Penelope
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 82 - 83
  • [3] Selenium (Se) deficiency in women with ovarian cancer undergoing chemotherapy and the influence of supplementation with this micro-element on biochemical parameters
    Sieja, K
    PHARMAZIE, 1998, 53 (07): : 473 - 476
  • [4] Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: A review of contributing factors
    Anderson, Nancy J.
    Hacker, Eileen D.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (03) : 445 - 454
  • [5] Centering Prayer for Women Receiving Chemotherapy for Recurrent Ovarian Cancer: A Pilot Study
    Johnson, Mary E.
    Dose, Ann M.
    Pipe, Teri Britt
    Petersen, Wesley O.
    Huschka, Mashele
    Gallenberg, Mary M.
    Peethambaram, Prema
    Sloan, Jeff
    Frost, Marlene H.
    ONCOLOGY NURSING FORUM, 2009, 36 (04) : 421 - 428
  • [6] Are The ACSM Exercise Guidelines Safe And Achievable For Women Receiving Chemotherapy For Ovarian Cancer?
    Jones, Tamara
    Spence, Rosalind
    Sandler, Carolina
    Obermair, Andreas
    Friedlander, Michael
    Mileshkin, Linda
    Davis, Alison
    Janda, Monika
    Eakin, Elizabeth
    Barnes, Elizabeth
    Beesley, Vanessa
    Gordon, Louisa
    Brand, Alison
    Hayes, Sandra
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2020, 52 (07) : 483 - 484
  • [7] Debulking Surgery and Intraperitoneal Chemotherapy Are Associated With Decreased Morbidity in Women Receiving Neoadjuvant Chemotherapy for Ovarian Cancer
    Robinson, William
    Cantillo, Evelyn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (01) : 43 - 47
  • [8] ANTICIPATORY IMMUNE SUPPRESSION AND NAUSEA IN WOMEN RECEIVING CYCLIC CHEMOTHERAPY FOR OVARIAN-CANCER
    BOVBJERG, DH
    REDD, WH
    MAIER, LA
    HOLLAND, JC
    LESKO, LM
    NIEDZWIECKI, D
    RUBIN, SC
    HAKES, TB
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (02) : 153 - 157
  • [9] For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
    Dizon, Don S.
    Restivo, Antonella
    Lomme, Michelle
    Charbonneau, Nicole
    Brard, Laurent
    Hughes, Tasha
    Weitzen, Sherry
    Legare, Robert
    Granai, C. O.
    DiSilvestro, Paul
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 39 - 42
  • [10] Selenium 'beneficial' in ovarian cancer treatment
    不详
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (10) : 1462 - 1462